( MENAFN - GlobeNewsWire - Nasdaq) NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C.
, a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc. (NYSE: AGL) on behalf of long-term stockholders following a class action complaint that was filed against Agilon on March 19, 2024 with Class Period (1) Agilon common stock purchases traceable to the April 2021 initial public offering of Agilon stock; (2) pursuant, or traceable, or both, to materials issued in connection with the Company's secondary public offering that occurred on or about May 16, 2023; and/or (3) common stock between April 15, 2021 and February 27, 2024. Our investigation concerns whether the board of directors of Agilon have breached their fiduciary duties to the company.
Agilon, headquartered in Austin, Texas, generates profits from reducing medical expenditures. By partnering primarily with Medicare Advantage (“MA”) plans as well as traditional Medicare and commercial managed care organizations, Agilon receives a fixed monthly payment from payers for each patient under its care. In return, Agilon takes on the responsibility of managing the total cost and quality of care for those patients.
This model incentivizes Agilon and its contracted physician partners to focus on preventive care and improve health outcomes in order to control costs. If the total cost of caring for patients is less than the fixed payments Agilon receives, it r.
